PFSA (Profusa, Inc.) Stock Market Reviews

crown

search

Read and share opinions on PFSA (Profusa, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

PFSA

Profusa, Inc.

clarify Medical Devices

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
Oct 30, 2025
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Oct 28, 2025
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
Oct 22, 2025
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base
Oct 1, 2025
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
Sep 11, 2025
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base
Sep 4, 2025
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Sep 2, 2025
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
Aug 27, 2025
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Aug 19, 2025
Profusa Secures Lumee™ Oxygen Platform Distributor in Spain
Jul 31, 2025
Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq
Jul 11, 2025

Reviews